{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:59:59Z","timestamp":1785502799469,"version":"3.56.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recurrent pregnancy loss (RPL) is a multifactorial reproductive disorder that affects approximately 1\u20135% of couples of reproductive age and is associated with considerable emotional and clinical burden. Although several genetic, anatomical, endocrine, infectious, and thrombophilic factors have been implicated, the underlying cause remains unexplained in nearly half of all cases, highlighting the importance of immune dysregulation in disease pathogenesis. Among immune factors, immunoglobulins play pivotal roles in maintaining maternal\u2013fetal immune homeostasis by regulating immune tolerance, complement activation, autoantibody production, and inflammatory signalling. However, dysregulated humoral immune responses may disrupt placental development and fetal tolerance, thereby contributing to pregnancy failure. This review summarises current evidence regarding the biological functions of immunoglobulins in normal pregnancy and their involvement in the pathogenesis of RPL. We discuss the clinical significance of immunoglobulin-associated biomarkers, including antiphospholipid, antinuclear, anti-thyroid, and other pregnancy-related autoantibodies, and evaluate their utility in risk stratification and diagnosis. Emerging immunoglobulin-based therapeutic strategies, particularly intravenous immunoglobulin (IVIG), are reviewed in the context of current clinical evidence and guideline recommendations. Finally, we highlight the potential of comprehensive immunoglobulin profiling, integrated with clinical and molecular biomarkers, to support precision medicine approaches for individualised diagnosis, prognosis, and therapeutic decision-making in women with RPL. Continued mechanistic and translational research will be essential to validate these biomarkers and optimise personalised immunomodulatory interventions for improving pregnancy outcomes.<\/jats:p>","DOI":"10.1007\/s11033-026-12514-2","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:03:06Z","timestamp":1785499386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets"],"prefix":"10.1007","volume":"53","author":[{"given":"Umme","family":"Kulsum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-1401","authenticated-orcid":false,"given":"K. S.","family":"Praveen Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Shekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naidu M.","family":"Swati Krishnaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshitha V.","family":"Jayakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana Hangala","family":"Shivakumaraswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Prashant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"12514_CR1","first-page":"76","volume":"2","author":"HB Ford","year":"2009","unstructured":"Ford HB, Schust DJ (2009) Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2:76\u201383","journal-title":"Rev Obstet Gynecol"},{"key":"12514_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2012) Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 98:1103\u20131111. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.048","journal-title":"Fertil Steril"},{"key":"12514_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.11604\/pamj.2025.52.109.46376","volume":"52","author":"A Bosire","year":"2025","unstructured":"Bosire A, Kosgei R, Gathara D et al (2025) Burden, causes, and treatment approaches of recurrent pregnancy loss: a scoping review. Pan Afr Med J 52:109. https:\/\/doi.org\/10.11604\/pamj.2025.52.109.46376","journal-title":"Pan Afr Med J"},{"key":"12514_CR4","doi-asserted-by":"publisher","first-page":"103785","DOI":"10.1016\/j.jri.2022.103785","volume":"155","author":"N Yu","year":"2023","unstructured":"Yu N, Kwak-Kim J, Bao S (2023) Unexplained recurrent pregnancy loss: Novel causes and advanced treatment. J Reprod Immunol 155:103785. https:\/\/doi.org\/10.1016\/j.jri.2022.103785","journal-title":"J Reprod Immunol"},{"key":"12514_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1515\/mr-2022-0030","volume":"2","author":"C Cao","year":"2022","unstructured":"Cao C, Bai S, Zhang J et al (2022) Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management. Med Rev 2:570\u2013589. https:\/\/doi.org\/10.1515\/mr-2022-0030","journal-title":"Med Rev"},{"key":"12514_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","volume":"63","author":"G Mor","year":"2010","unstructured":"Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63:425\u2013433. https:\/\/doi.org\/10.1111\/j.1600-0897.2010.00836.x","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR7","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.4110\/in.2024.24.e30","volume":"24","author":"JS Joo","year":"2024","unstructured":"Joo JS, Lee D, Hong JY (2024) Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface. Immune Netw 24:e30. https:\/\/doi.org\/10.4110\/in.2024.24.e30","journal-title":"Immune Netw"},{"key":"12514_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-immunol-032712-100003","volume":"31","author":"A Erlebacher","year":"2013","unstructured":"Erlebacher A (2013) Immunology of the maternal-fetal interface. Annu Rev Immunol 31:387\u2013411. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-100003","journal-title":"Annu Rev Immunol"},{"key":"12514_CR9","doi-asserted-by":"publisher","first-page":"e12600","DOI":"10.1002\/rmb2.12600","volume":"23","author":"S Saito","year":"2024","unstructured":"Saito S (2024) Role of immune cells in the establishment of implantation and maintenance of pregnancy and immunomodulatory therapies for patients with repeated implantation failure and recurrent pregnancy loss. Reprod Med Biol 23:e12600. https:\/\/doi.org\/10.1002\/rmb2.12600","journal-title":"Reprod Med Biol"},{"key":"12514_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1600-0897.2010.00847.x","volume":"63","author":"J Kwak-Kim","year":"2010","unstructured":"Kwak-Kim J, Park JC, Ahn HK et al (2010) Immunological modes of pregnancy loss. Am J Reprod Immunol 63:611\u2013623. https:\/\/doi.org\/10.1111\/j.1600-0897.2010.00847.x","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR11","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/cpr.70037","volume":"58","author":"D Guan","year":"2025","unstructured":"Guan D, Chen Z, Zhang Y et al (2025) Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure. Cell Prolif 58:e70037. https:\/\/doi.org\/10.1111\/cpr.70037","journal-title":"Cell Prolif"},{"key":"12514_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev-pathmechdis-111523-023459","volume":"20","author":"G Rizzuto","year":"2025","unstructured":"Rizzuto G (2025) B Cell Responses to the Placenta and Fetus. Annu Rev Pathol 20:33\u201358. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-111523-023459","journal-title":"Annu Rev Pathol"},{"key":"12514_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","volume":"368","author":"R Rai","year":"2006","unstructured":"Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601\u2013611. https:\/\/doi.org\/10.1016\/S0140-6736(06)69204-0","journal-title":"Lancet"},{"key":"12514_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/humupd\/dmt056","volume":"20","author":"S Seshadri","year":"2014","unstructured":"Seshadri S, Sunkara SK (2014) Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 20:429\u2013438. https:\/\/doi.org\/10.1093\/humupd\/dmt056","journal-title":"Hum Reprod Update"},{"key":"12514_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fimmu.2015.00469","volume":"6","author":"GN Kaufman","year":"2015","unstructured":"Kaufman GN, Massoud AH, Dembele M et al (2015) Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity. Front Immunol 6:469. https:\/\/doi.org\/10.3389\/fimmu.2015.00469","journal-title":"Front Immunol"},{"key":"12514_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaip.2023.04.002","volume":"11","author":"J Bayry","year":"2023","unstructured":"Bayry J, Ahmed EA, Toscano-Rivero D et al (2023) Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions. J Allergy Clin Immunol Pract 11:1688\u20131697. https:\/\/doi.org\/10.1016\/j.jaip.2023.04.002","journal-title":"J Allergy Clin Immunol Pract"},{"key":"12514_CR17","doi-asserted-by":"publisher","first-page":"101527","DOI":"10.1016\/j.eclinm.2022.101527","volume":"50","author":"H Yamada","year":"2022","unstructured":"Yamada H, Deguchi M, Saito S et al (2022) Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial. EClinicalMedicine 50:101527. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101527","journal-title":"EClinicalMedicine"},{"key":"12514_CR18","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.3346\/jkms.2022.37.e200","volume":"37","author":"JH Kim","year":"2022","unstructured":"Kim JH, Kim SH, Yang N et al (2022) Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. J Korean Med Sci 37:e200. https:\/\/doi.org\/10.3346\/jkms.2022.37.e200","journal-title":"J Korean Med Sci"},{"key":"12514_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/jcm10040869","volume":"10","author":"K Vomstein","year":"2021","unstructured":"Vomstein K, Feil K, Strobel L et al (2021) Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art. J Clin Med 10:869. https:\/\/doi.org\/10.3390\/jcm10040869","journal-title":"J Clin Med"},{"key":"12514_CR20","doi-asserted-by":"publisher","first-page":"e56555","DOI":"10.7759\/cureus.56555","volume":"16","author":"Z Kirovakov","year":"2024","unstructured":"Kirovakov Z, Konova E, Hinkova N et al (2024) Immunological Risk Factors in Recurrent Pregnancy Loss in Patients With Hereditary Thrombophilia. Cureus 16:e56555. https:\/\/doi.org\/10.7759\/cureus.56555","journal-title":"Cureus"},{"key":"12514_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/IJWH.S100817","volume":"9","author":"H El Hachem","year":"2017","unstructured":"El Hachem H, Crepaux V, May-Panloup P et al (2017) Recurrent pregnancy loss: current perspectives. Int J Womens Health 9:331\u2013345. https:\/\/doi.org\/10.2147\/IJWH.S100817","journal-title":"Int J Womens Health"},{"key":"12514_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","volume":"6","author":"E Dimitriadis","year":"2020","unstructured":"Dimitriadis E, Menkhorst E, Saito S et al (2020) Recurrent pregnancy loss. Nat Rev Dis Primer 6:98. https:\/\/doi.org\/10.1038\/s41572-020-00228-z","journal-title":"Nat Rev Dis Primer"},{"key":"12514_CR23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.fertnstert.2023.08.954","volume":"120","author":"HG Genovese","year":"2023","unstructured":"Genovese HG, McQueen DB (2023) The prevalence of sporadic and recurrent pregnancy loss. Fertil Steril 120:934\u2013936. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.08.954","journal-title":"Fertil Steril"},{"key":"12514_CR24","doi-asserted-by":"publisher","first-page":"1805994","DOI":"10.3389\/fmed.2026.1805994","volume":"13","author":"T Carvalho","year":"2026","unstructured":"Carvalho T, \u00c2ngelo-Dias M, Moutinho F et al (2026) Recurrent pregnancy loss: systematic review and meta-analysis of overall prevalence and the distribution of major etiological categories. Front Med 13:1805994. https:\/\/doi.org\/10.3389\/fmed.2026.1805994","journal-title":"Front Med"},{"key":"12514_CR25","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3390\/jcm12124074","volume":"12","author":"A Turesheva","year":"2023","unstructured":"Turesheva A, Aimagambetova G, Ukybassova T et al (2023) Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box. J Clin Med 12:4074. https:\/\/doi.org\/10.3390\/jcm12124074","journal-title":"J Clin Med"},{"key":"12514_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12955-021-01703-1","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng Z, Pei J et al (2021) Anxiety and depression are risk factors for recurrent pregnancy loss: a nested case-control study. Health Qual Life Outcomes 19:78. https:\/\/doi.org\/10.1186\/s12955-021-01703-1","journal-title":"Health Qual Life Outcomes"},{"key":"12514_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/biology14070877","volume":"14","author":"E Moustakli","year":"2025","unstructured":"Moustakli E, Potiris A, Zikopoulos A et al (2025) Immunological Factors in Recurrent Pregnancy Loss: Mechanisms, Controversies, and Emerging Therapies. Biology 14:877. https:\/\/doi.org\/10.3390\/biology14070877","journal-title":"Biology"},{"key":"12514_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2017.64","volume":"17","author":"G Mor","year":"2017","unstructured":"Mor G, Aldo P, Alvero AB (2017) The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 17:469\u2013482. https:\/\/doi.org\/10.1038\/nri.2017.64","journal-title":"Nat Rev Immunol"},{"key":"12514_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/aji.12234","volume":"72","author":"J Kwak-Kim","year":"2014","unstructured":"Kwak-Kim J, Bao S, Lee SK et al (2014) Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol 72:129\u2013140. https:\/\/doi.org\/10.1111\/aji.12234","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR30","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.fertnstert.2009.11.020","volume":"94","author":"S Mei","year":"2010","unstructured":"Mei S, Tan J, Chen H et al (2010) Changes of CD4\u2009+\u2009CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril 94:2244\u20132247. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.020","journal-title":"Fertil Steril"},{"key":"12514_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito S, Nakashima A, Shima T, Ito M (2010) Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63:601\u2013610. https:\/\/doi.org\/10.1111\/j.1600-0897.2010.00852.x","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.07.005","volume":"60","author":"H Carp","year":"2019","unstructured":"Carp H (2019) Immunotherapy for recurrent pregnancy loss. Best Pract Res Clin Obstet Gynaecol 60:77\u201386. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.07.005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"12514_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ni1037","volume":"5","author":"VR Aluvihare","year":"2004","unstructured":"Aluvihare VR, Kallikourdis M, Betz AG (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5:266\u2013271. https:\/\/doi.org\/10.1038\/ni1037","journal-title":"Nat Immunol"},{"key":"12514_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/aji.12094","volume":"69","author":"T Tilburgs","year":"2013","unstructured":"Tilburgs T, Strominger JL (2013) CD8\u2009+\u2009effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am J Reprod Immunol 69:395\u2013407. https:\/\/doi.org\/10.1111\/aji.12094","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR35","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","volume":"12","author":"J Hanna","year":"2006","unstructured":"Hanna J, Goldman-Wohl D, Hamani Y et al (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12:1065\u20131074. https:\/\/doi.org\/10.1038\/nm1452","journal-title":"Nat Med"},{"key":"12514_CR36","doi-asserted-by":"publisher","unstructured":"Lash GE, Robson SC, Bulmer JN (2010) Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. https:\/\/doi.org\/10.1016\/j.placenta.2009.12.022. Placenta 31 Suppl:S87-92","DOI":"10.1016\/j.placenta.2009.12.022"},{"key":"12514_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13223-022-00660-8","volume":"18","author":"DHJ Habets","year":"2022","unstructured":"Habets DHJ, Pelzner K, Wieten L et al (2022) Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol 18:23. https:\/\/doi.org\/10.1186\/s13223-022-00660-8","journal-title":"Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol"},{"key":"12514_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28:521\u2013574. https:\/\/doi.org\/10.1210\/er.2007-0001","journal-title":"Endocr Rev"},{"key":"12514_CR39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/aji.12157","volume":"70","author":"L Rolle","year":"2013","unstructured":"Rolle L, Memarzadeh Tehran M, Morell-Garc\u00eda A et al (2013) Cutting edge: IL-10-producing regulatory B cells in early human pregnancy. Am J Reprod Immunol 70:448\u2013453. https:\/\/doi.org\/10.1111\/aji.12157","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR40","doi-asserted-by":"publisher","first-page":"985646","DOI":"10.1155\/2012\/985646","volume":"2012","author":"P Palmeira","year":"2012","unstructured":"Palmeira P, Quinello C, Silveira-Lessa AL et al (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012:985646. https:\/\/doi.org\/10.1155\/2012\/985646","journal-title":"Clin Dev Immunol"},{"key":"12514_CR41","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder","year":"2010","unstructured":"Schroeder HW, Cavacini L (2010) Structure and function of immunoglobulins. J Allergy Clin Immunol 125:S41\u201352. https:\/\/doi.org\/10.1016\/j.jaci.2009.09.046","journal-title":"J Allergy Clin Immunol"},{"key":"12514_CR42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/s0161-5890(01)00025-6","volume":"37","author":"M Boes","year":"2000","unstructured":"Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37:1141\u20131149. https:\/\/doi.org\/10.1016\/s0161-5890(01)00025-6","journal-title":"Mol Immunol"},{"key":"12514_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2567.2004.01958.x","volume":"113","author":"JM Woof","year":"2004","unstructured":"Woof JM, Kerr MA (2004) IgA function\u2013variations on a theme. Immunology 113:175\u2013177. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01958.x","journal-title":"Immunology"},{"key":"12514_CR44","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1016\/s0264-410x(03)00334-7","volume":"21","author":"NE Simister","year":"2003","unstructured":"Simister NE (2003) Placental transport of immunoglobulin G. Vaccine 21:3365\u20133369. https:\/\/doi.org\/10.1016\/s0264-410x(03)00334-7","journal-title":"Vaccine"},{"key":"12514_CR45","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein MR, Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10:778\u2013786. https:\/\/doi.org\/10.1038\/nri2849","journal-title":"Nat Rev Immunol"},{"key":"12514_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost JTH 4:295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost JTH"},{"key":"12514_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1586\/1744666X.3.5.721","volume":"3","author":"M Satoh","year":"2007","unstructured":"Satoh M, Chan EK, Sobel ES et al (2007) Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 3:721\u2013738. https:\/\/doi.org\/10.1586\/1744666X.3.5.721","journal-title":"Expert Rev Clin Immunol"},{"key":"12514_CR48","doi-asserted-by":"publisher","first-page":"d2616","DOI":"10.1136\/bmj.d2616","volume":"342","author":"S Thangaratinam","year":"2011","unstructured":"Thangaratinam S, Tan A, Knox E et al (2011) Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 342:d2616. https:\/\/doi.org\/10.1136\/bmj.d2616","journal-title":"BMJ"},{"key":"12514_CR49","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.jri.2025.104736","volume":"172","author":"A Aoki","year":"2025","unstructured":"Aoki A, Sugi T, Kawana K (2025) Autoantibody-mediated disruption of the epidermal growth factor system during implantation and pregnancy. J Reprod Immunol 172:104736. https:\/\/doi.org\/10.1016\/j.jri.2025.104736","journal-title":"J Reprod Immunol"},{"key":"12514_CR50","doi-asserted-by":"publisher","first-page":"e13337","DOI":"10.1111\/aji.13337","volume":"85","author":"H Shibahara","year":"2021","unstructured":"Shibahara H, Wakimoto Y, Fukui A, Hasegawa A (2021) Anti-sperm antibodies and reproductive failures. Am J Reprod Immunol 85:e13337. https:\/\/doi.org\/10.1111\/aji.13337","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR51","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jth.13976","volume":"16","author":"KMJ Devreese","year":"2018","unstructured":"Devreese KMJ, Ortel TL, Pengo V et al (2018) Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost JTH 16:809\u2013813. https:\/\/doi.org\/10.1111\/jth.13976","journal-title":"J Thromb Haemost JTH"},{"key":"12514_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7:330\u2013339. https:\/\/doi.org\/10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"key":"12514_CR53","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/s0029-7844(03)00363-6","volume":"101","author":"DW Branch","year":"2003","unstructured":"Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 101:1333\u20131344. https:\/\/doi.org\/10.1016\/s0029-7844(03)00363-6","journal-title":"Obstet Gynecol"},{"key":"12514_CR54","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.semarthrit.2020.03.016","volume":"50","author":"S Chen","year":"2020","unstructured":"Chen S, Yang G, Wu P et al (2020) Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis. Semin Arthritis Rheum 50:534\u2013543. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.016","journal-title":"Semin Arthritis Rheum"},{"key":"12514_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00404-023-07001-z","volume":"308","author":"C Ticconi","year":"2023","unstructured":"Ticconi C, Nicastri E, D\u2019Ippolito S et al (2023) Diagnostic factors for recurrent pregnancy loss: an expanded workup. Arch Gynecol Obstet 308:127\u2013142. https:\/\/doi.org\/10.1007\/s00404-023-07001-z","journal-title":"Arch Gynecol Obstet"},{"key":"12514_CR56","doi-asserted-by":"publisher","first-page":"873286","DOI":"10.3389\/fendo.2022.873286","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu T, Guo X, Liao Y et al (2022) Correlation Between the Presence of Antinuclear Antibodies and Recurrent Pregnancy Loss: A Mini Review. Front Endocrinol 13:873286. https:\/\/doi.org\/10.3389\/fendo.2022.873286","journal-title":"Front Endocrinol"},{"key":"12514_CR57","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1007\/s43032-024-01725-2","volume":"31","author":"RR Finan","year":"2024","unstructured":"Finan RR, Beydoun N, Racoubian E et al (2024) High Prevalence of Anti-Prothrombin IgM and IgG Autoantibodies in Women With Unexplained Recurrent Pregnancy Loss. Reprod Sci 31:3851\u20133857. https:\/\/doi.org\/10.1007\/s43032-024-01725-2","journal-title":"Reprod Sci"},{"key":"12514_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.fertnstert.2019.11.003","volume":"113","author":"AC Dong","year":"2020","unstructured":"Dong AC, Morgan J, Kane M et al (2020) Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril 113:587\u2013600e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.003","journal-title":"Fertil Steril"},{"key":"12514_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195:211\u2013220. https:\/\/doi.org\/10.1084\/jem.200116116","journal-title":"J Exp Med"},{"key":"12514_CR60","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1084\/jem.20061022","volume":"203","author":"G Girardi","year":"2006","unstructured":"Girardi G, Yarilin D, Thurman JM et al (2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 203:2165\u20132175. https:\/\/doi.org\/10.1084\/jem.20061022","journal-title":"J Exp Med"},{"key":"12514_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/10935266231176682","volume":"26","author":"ES Chan","year":"2023","unstructured":"Chan ES, de Koning L, Yu W, Chadha R (2023) C4d Staining Is Present in Normal Placentas From Pregnancies Prior to Pregnancy Loss Associated With Chronic Histiocytic Intervillositis and Is Reduced by Immunomodulatory Therapy in Subsequent Pregnancies. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc 26:374\u2013387. https:\/\/doi.org\/10.1177\/10935266231176682","journal-title":"Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc"},{"key":"12514_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/OGX.0b013e3181c97809","volume":"65","author":"J Alijotas-Reig","year":"2010","unstructured":"Alijotas-Reig J, Vilardell-Tarres M (2010) Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 65:39\u201345. https:\/\/doi.org\/10.1097\/OGX.0b013e3181c97809","journal-title":"Obstet Gynecol Surv"},{"key":"12514_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejogrb.2009.04.002","volume":"145","author":"J Alijotas-Reig","year":"2009","unstructured":"Alijotas-Reig J, Palacio-Garcia C, Vilardell-Tarres M (2009) Circulating microparticles, lupus anticoagulant and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 145:22\u201326. https:\/\/doi.org\/10.1016\/j.ejogrb.2009.04.002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"12514_CR64","doi-asserted-by":"publisher","unstructured":"Flood K, Peace A, Kent E et al (2010) Platelet reactivity and pregnancy loss. Am J Obstet Gynecol 203. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.023. :281.e1\u20135","DOI":"10.1016\/j.ajog.2010.06.023"},{"key":"12514_CR65","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/biomedicines9121756","volume":"9","author":"J Kornacki","year":"2021","unstructured":"Kornacki J, Gutaj P, Kalantarova A et al (2021) Endothelial Dysfunction in Pregnancy Complications. Biomedicines 9:1756. https:\/\/doi.org\/10.3390\/biomedicines9121756","journal-title":"Biomedicines"},{"key":"12514_CR66","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033\u20131044. https:\/\/doi.org\/10.1056\/NEJMra1112830","journal-title":"N Engl J Med"},{"key":"12514_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34\u201347. https:\/\/doi.org\/10.1038\/nri2206","journal-title":"Nat Rev Immunol"},{"key":"12514_CR68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","volume":"236","author":"F Nimmerjahn","year":"2010","unstructured":"Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev 236:265\u2013275. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00910.x","journal-title":"Immunol Rev"},{"key":"12514_CR69","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C (2015) Regulatory B cells: origin, phenotype, and function. Immunity 42:607\u2013612. https:\/\/doi.org\/10.1016\/j.immuni.2015.04.005","journal-title":"Immunity"},{"key":"12514_CR70","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","volume":"28","author":"K Yanaba","year":"2008","unstructured":"Yanaba K, Bouaziz J-D, Haas KM et al (2008) A regulatory B cell subset with a unique CD1dhiCD5\u2009+\u2009phenotype controls T cell-dependent inflammatory responses. Immunity 28:639\u2013650. https:\/\/doi.org\/10.1016\/j.immuni.2008.03.017","journal-title":"Immunity"},{"key":"12514_CR71","doi-asserted-by":"publisher","first-page":"106806","DOI":"10.1016\/j.intimp.2020.106806","volume":"87","author":"S Danaii","year":"2020","unstructured":"Danaii S, Ghorbani F, Ahmadi M et al (2020) IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss. Int Immunopharmacol 87:106806. https:\/\/doi.org\/10.1016\/j.intimp.2020.106806","journal-title":"Int Immunopharmacol"},{"key":"12514_CR72","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12964-026-02669-7","volume":"24","author":"F Ma","year":"2026","unstructured":"Ma F, Xu Q, Xu L et al (2026) Reprogramming the epigenetic profile improves the B regulatory cell function of patients with recurrent pregnancy loss. Cell Commun Signal CCS 24:118. https:\/\/doi.org\/10.1186\/s12964-026-02669-7","journal-title":"Cell Commun Signal CCS"},{"key":"12514_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10719-012-9381-6","volume":"30","author":"HK Einarsdottir","year":"2013","unstructured":"Einarsdottir HK, Selman MHJ, Kapur R et al (2013) Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J 30:147\u2013157. https:\/\/doi.org\/10.1007\/s10719-012-9381-6","journal-title":"Glycoconj J"},{"key":"12514_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/aji.12289","volume":"72","author":"K Racicot","year":"2014","unstructured":"Racicot K, Kwon J-Y, Aldo P et al (2014) Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol 72:107\u2013116. https:\/\/doi.org\/10.1111\/aji.12289","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30:221\u2013241. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074934","journal-title":"Annu Rev Immunol"},{"key":"12514_CR76","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1172\/JCI68107","volume":"124","author":"A Moffett","year":"2014","unstructured":"Moffett A, Colucci F (2014) Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest 124:1872\u20131879. https:\/\/doi.org\/10.1172\/JCI68107","journal-title":"J Clin Invest"},{"key":"12514_CR77","doi-asserted-by":"publisher","first-page":"eaat6114","DOI":"10.1126\/sciimmunol.aat6114","volume":"4","author":"SE Ander","year":"2019","unstructured":"Ander SE, Diamond MS, Coyne CB (2019) Immune responses at the maternal-fetal interface. Sci Immunol 4:eaat6114. https:\/\/doi.org\/10.1126\/sciimmunol.aat6114","journal-title":"Sci Immunol"},{"key":"12514_CR78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/tan.12737","volume":"87","author":"MHC Craenmehr","year":"2016","unstructured":"Craenmehr MHC, Heidt S, Eikmans M, Claas FHJ (2016) What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages? HLA 87:69\u201378. https:\/\/doi.org\/10.1111\/tan.12737","journal-title":"HLA"},{"key":"12514_CR79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/GRF.0b013e31802f1c28","volume":"50","author":"M Stephenson","year":"2007","unstructured":"Stephenson M, Kutteh W (2007) Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 50:132\u2013145. https:\/\/doi.org\/10.1097\/GRF.0b013e31802f1c28","journal-title":"Clin Obstet Gynecol"},{"key":"12514_CR80","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","volume":"13","author":"I Schwab","year":"2013","unstructured":"Schwab I, Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13:176\u2013189. https:\/\/doi.org\/10.1038\/nri3401","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"12514_CR81","first-page":"21","volume":"104","author":"M Basta","year":"1996","unstructured":"Basta M (1996) Modulation of complement-mediated immune damage by intravenous immune globulin. Clin Exp Immunol 104(Suppl 1):21\u201325","journal-title":"Clin Exp Immunol"},{"key":"12514_CR82","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.jri.2025.104541","volume":"170","author":"L Kofod","year":"2025","unstructured":"Kofod L, Pedersen M, Andersen M et al (2025) Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trials. J Reprod Immunol 170:104541. https:\/\/doi.org\/10.1016\/j.jri.2025.104541","journal-title":"J Reprod Immunol"},{"key":"12514_CR83","doi-asserted-by":"publisher","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","volume":"2018","author":"R Bender Atik","year":"2018","unstructured":"ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB et al (2018) ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018:hoy004. https:\/\/doi.org\/10.1093\/hropen\/hoy004","journal-title":"Hum Reprod Open"},{"key":"12514_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","volume":"6","author":"U Katz","year":"2007","unstructured":"Katz U, Achiron A, Sherer Y, Shoenfeld Y (2007) Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 6:257\u2013259. https:\/\/doi.org\/10.1016\/j.autrev.2006.08.011","journal-title":"Autoimmun Rev"},{"key":"12514_CR85","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520. https:\/\/doi.org\/10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"key":"12514_CR86","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10067-023-06843-x","volume":"43","author":"J Chen","year":"2024","unstructured":"Chen J, Yue J, Lu Y et al (2024) Recurrent miscarriage and low-titer antiphospholipid antibodies. Clin Rheumatol 43:1327\u20131334. https:\/\/doi.org\/10.1007\/s10067-023-06843-x","journal-title":"Clin Rheumatol"},{"key":"12514_CR87","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.4103\/jfmpc.jfmpc_485_24","volume":"13","author":"SC Ekka","year":"2024","unstructured":"Ekka SC, Sinha MBK, Kumari A (2024) A study of autoimmune thyroid disease in pregnant women and its effect on fetal and maternal outcome. J Fam Med Prim Care 13:4916\u20134925. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_485_24","journal-title":"J Fam Med Prim Care"},{"key":"12514_CR88","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1600-0897.2012.01182.x","volume":"68","author":"RD Saunders","year":"2012","unstructured":"Saunders RD, Nakajima ST, Rai SN et al (2012) Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and \u03b12-macroglobulin in women with recurrent pregnancy loss. Am J Reprod Immunol 68:438\u2013449. https:\/\/doi.org\/10.1111\/j.1600-0897.2012.01182.x","journal-title":"Am J Reprod Immunol"},{"key":"12514_CR89","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.it.2017.02.004","volume":"38","author":"MF Jennewein","year":"2017","unstructured":"Jennewein MF, Alter G (2017) The Immunoregulatory Roles of Antibody Glycosylation. Trends Immunol 38:358\u2013372. https:\/\/doi.org\/10.1016\/j.it.2017.02.004","journal-title":"Trends Immunol"},{"key":"12514_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-026-02831-1","author":"L Zhang","year":"2026","unstructured":"Zhang L, Feng Y, Zhang Y et al (2026) Defective HLA-G1 glycosylation disrupts Siglec-7-mediated NK cell tolerance at the maternal-fetal interface in recurrent pregnancy loss. Cell Commun Signal CCS. https:\/\/doi.org\/10.1186\/s12964-026-02831-1","journal-title":"Cell Commun Signal CCS"},{"key":"12514_CR93","doi-asserted-by":"publisher","first-page":"1453336","DOI":"10.3389\/fendo.2024.1453336","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Diao L (2024) Editorial: Recurrent pregnancy loss and endocrine dysfunction. Front Endocrinol 15:1453336. https:\/\/doi.org\/10.3389\/fendo.2024.1453336","journal-title":"Front Endocrinol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12514-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:03:08Z","timestamp":1785499388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12514"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12514-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Authors declare that they do not have a conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a review article and does not involve human participants or animal subjects. Therefore, ethical approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1317"}}